Showing 511-520 of 758 results for "".
Aesthetic Dermatology in 2021
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aesthetic-dermatology-in-2021/23468/A look at how the COVID-19 pandemic has affected the demand for aesthetic procedures in dermatology offices around the country.Therapeutic Focus: Laser and Light Therapy
https://practicaldermatology.com/topics/general-topics/therapeutic-focus-laser-and-light-therapy/21384/New products and pharmacologic developments2019 In Review
https://practicaldermatology.com/topics/practice-management/2019-in-review/23168/A look back at approvals, data, and industry developments of the year.Biosimilars: Generic Biologics or Something Much More Complex?
https://practicaldermatology.com/topics/practice-management/biosimilars-generic-biologics-or-something-much-more-complex/21013/The looming availability of biosimilar medications raises important clinical and regulatory questions.EGFR Inhibitor-induced Acneiform Rash: A Review of Current Management Strategies
https://practicaldermatology.com/topics/general-topics/egfr-inhibitor-induced-acneiform-rash-a-review-of-current-management-strategies/21517/Update on Human Safety and the Environmental Impact of Physical and Chemical Sunscreen Filters
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-on-human-safety-and-the-environmental-impact-of-physical-and-chemical-sunscreen-filters/20800/What do we know about the effects of these commonly used and important molecules?Indoor Tanning Beds: The Dangers of Adolescent Tanning
https://practicaldermatology.com/topics/skin-cancer-photoprotection/indoor-tanning-beds-the-dangers-of-adolescent-tanning/22972/As research continues to shed light on the connection between UV exposure and skin cancer, greater efforts are required to inform the public and affect the legislative process.Management of Atopic Dermatitis During the COVID-19 Pandemic
https://practicaldermatology.com/topics/atopic-dermatitis/management-of-atopic-dermatitis-during-the-covid-19-pandemic/23322/There is concern about the immunosuppressive or immunomodulatory effects of oral and biologic medications in patients with skin disease.The Microbiome in Atopic Dermatitis: Where Are We Now?
https://practicaldermatology.com/topics/atopic-dermatitis/the-microbiome-in-atopic-dermatitis-where-are-we-now/23746/It seems increasingly likely that microbes will play a central role in understanding AD and its treatments.Are We Overlooking Skin Cancer in Ethnic Minorities?
https://practicaldermatology.com/issues/supplements/are-we-overlooking-skin-cancer-in-ethnic-minorities/21718/Skin cancers in Hispanic and African American patients may be detected at more advanced stages, leading to poorer prognoses and long-term outcomes compared to non-Hispanic whites.